Literature DB >> 11781351

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.

Joanna Groom1, Susan L Kalled, Anne H Cutler, Carl Olson, Stephen A Woodcock, Pascal Schneider, Jurg Tschopp, Teresa G Cachero, Marcel Batten, Julie Wheway, Davide Mauri, Dana Cavill, Tom P Gordon, Charles R Mackay, Fabienne Mackay.   

Abstract

BAFF (BLyS, TALL-1, THANK, zTNF4) is a member of the TNF superfamily that specifically regulates B lymphocyte proliferation and survival. Mice transgenic (Tg) for BAFF develop an autoimmune condition similar to systemic lupus erythematosus. We now demonstrate that BAFF Tg mice, as they age, develop a secondary pathology reminiscent of Sjögren's syndrome (SS), which is manifested by severe sialadenitis, decreased saliva production, and destruction of submaxillary glands. In humans, SS also correlates with elevated levels of circulating BAFF, as well as a dramatic upregulation of BAFF expression in inflamed salivary glands. A likely explanation for disease in BAFF Tg mice is excessive survival signals to autoreactive B cells, possibly as they pass through a critical tolerance checkpoint while maturing in the spleen. The marginal zone (MZ) B cell compartment, one of the enlarged B cell subsets in the spleen of BAFF Tg mice, is a potential reservoir of autoreactive B cells. Interestingly, B cells with an MZ-like phenotype infiltrate the salivary glands of BAFF Tg mice, suggesting that cells of this compartment potentially participate in tissue damage in SS and possibly other autoimmune diseases. We conclude that altered B cell differentiation and tolerance induced by excess BAFF may be central to SS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781351      PMCID: PMC150825          DOI: 10.1172/JCI14121

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice.

Authors:  D Zeng; M K Lee; J Tung; A Brendolan; S Strober
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

2.  Decoy receptors thwart B cells.

Authors:  C F Ware
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

3.  B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals.

Authors:  F Loder; B Mutschler; R J Ray; C J Paige; P Sideras; R Torres; M C Lamers; R Carsetti
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

4.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.

Authors:  J A Gross; J Johnston; S Mudri; R Enselman; S R Dillon; K Madden; W Xu; J Parrish-Novak; D Foster; C Lofton-Day; M Moore; A Littau; A Grossman; H Haugen; K Foley; H Blumberg; K Harrison; W Kindsvogel; C H Clegg
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

5.  Induction of experimental autoallergic sialadenitis.

Authors:  S C White; G W Casarett
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

6.  B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1.

Authors:  H B Shu; H Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Immunology. Lymphocyte survival--ignorance is BLys.

Authors:  Y Laâbi; A Strasser
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

8.  Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.

Authors:  R K Do; E Hatada; H Lee; M R Tourigny; D Hilbert; S Chen-Kiang
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

9.  BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population.

Authors:  J S Thompson; P Schneider; S L Kalled; L Wang; E A Lefevre; T G Cachero; F MacKay; S A Bixler; M Zafari; Z Y Liu; S A Woodcock; F Qian; M Batten; C Madry; Y Richard; C D Benjamin; J L Browning; A Tsapis; J Tschopp; C Ambrose
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

10.  TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation.

Authors:  X Z Xia; J Treanor; G Senaldi; S D Khare; T Boone; M Kelley; L E Theill; A Colombero; I Solovyev; F Lee; S McCabe; R Elliott; K Miner; N Hawkins; J Guo; M Stolina; G Yu; J Wang; J Delaney; S Y Meng; W J Boyle; H Hsu
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

View more
  258 in total

1.  The buzz about BAFF.

Authors:  David L Vaux
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Sjögren's syndrome criteria.

Authors:  R Manthorpe
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway.

Authors:  Jennifer L Gommerman; Fabienne Mackay; Elina Donskoy; Werner Meier; Pauline Martin; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  Regulation of B cell activating factor (BAFF) receptor expression by NF-ΚB signaling in rheumatoid arthritis B cells.

Authors:  Yun Ju Woo; Bo Young Yoon; Joo Yeon Jhun; Hye Jwa Oh; Se Won Min; Mi La Cho; Sung Hwan Park; Ho Youn Kim; Jun Ki Min
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

Review 5.  Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.

Authors:  M R Kok; B J Baum; P P Tak; S R Pillemer
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 6.  Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome.

Authors:  Roland Jonsson; Tom P Gordon; Yrjö T Konttinen
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

Review 7.  The role of epithelial cells in the pathogenesis of Sjögren's syndrome.

Authors:  Menelaos N Manoussakis; Efstathia K Kapsogeorgou
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 8.  Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.

Authors:  Michael Voulgarelis; Fotini N Skopouli
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

9.  Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.

Authors:  Jill M Kramer; Nichol E Holodick; Teresa C Vizconde; Indu Raman; Mei Yan; Quan-Zhen Li; Daniel P Gaile; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2015-09-17       Impact factor: 4.962

Review 10.  Emerging cell and cytokine targets in rheumatoid arthritis.

Authors:  Gerd R Burmester; Eugen Feist; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2013-11-12       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.